Click Therapeutics
Develops prescription software to treat medical conditions via smartphones.
Company facts
- Founded
- 2012
- Employees
- 160
- Headquarters
- United States
- CEO
- David Benshoof Klein
- Type
- Private
- Funding
- Series C · $48.6M · 2025
About
Click Therapeutics, Inc. is at the forefront of digital medicine, offering innovative solutions to those dealing with unmet medical needs. We specialize in developing, validating, and commercializing software as prescription medical treatments aimed at enhancing the health and wellness of individuals through our pioneering Digital Therapeutics™. These therapeutics are designed to facilitate cognitive and neurobehavioral changes, empowering patients to actively engage with their health. Established in 2012 and based in New York, we’re dedicated to advancing digital medicine that is evidence-based and user-friendly. Our solutions cater to a variety of medical conditions, including smoking cessation, major depressive disorder, and schizophrenia. Through collaborations with key partners and adherence to FDA and ISO regulations, our team is committed to ensuring our digital therapeutics are clinically validated, safe, and effective. We believe that by leveraging technology, we can make significant strides in improving patient outcomes and expanding access to essential healthcare.